Micafungin Sodium is Used for treating candidiasis infections in various settings, including esophageal candidiasis, candidemia, and candida peritonitis. It was first introduced by Astellas Pharma Us Inc in its drug Mycamine on Mar 16, 2005. Other drugs containing Micafungin Sodium are Micafungin In Sodium Chloride 0.9%, Micafungin. 12 different companies have introduced drugs containing Micafungin Sodium.
Micafungin Sodium Patents
Given below is the list of patents protecting Micafungin Sodium, along
with the drug name that holds that patent and the company name owning that
drug.
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List
Micafungin Sodium Generic API Manufacturers
Several generic applications have been filed for Micafungin Sodium. The first generic version for Micafungin Sodium was by Fresenius Kabi Usa Llc and was approved on May 17, 2019. And the latest generic version is by Biocon Pharma Ltd and was approved on May 29, 2024.
Given below is the list of companies who have filed for
Micafungin Sodium generic, along with the locations of their manufacturing plants worldwide.
1. APOTEX
Apotex Inc has filed for 2 different strengths of generic version for Micafungin Sodium. Given below are the
details of the strengths of this generic introduced by
Apotex.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 50MG BASE/VIAL
injectable
Discontinued
INTRAVENOUS
N/A
Nov 5, 2020
EQ 100MG BASE/VIAL
injectable
Discontinued
INTRAVENOUS
N/A
Nov 5, 2020
Manufacturing Plant Locations
New
Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.
Country
City
Firm Name
United States
Weston
Apotex Corp.
Canada
Brantford
Apotex Pharmachem Inc.
Winnipeg
Apotex Fermentation Inc.
Etobicoke
Apotex, Inc.
North York
Apotex Inc.
Richmond Hill
Apotex Inc.
Toronto
Apotex Inc.
India
Bangalore
Apotex Research Private Limited - Bioequivalence Centre
Bengaluru
Apotex Research Private Limited
Bangalore
Apotex Pharmachem India Pvt Ltd.
2. BIOCON PHARMA
Biocon Pharma Ltd has filed for 2 different strengths of generic version for Micafungin Sodium. Given below are the
details of the strengths of this generic introduced by
Biocon Pharma.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 100MG BASE/VIAL
injectable
Prescription
INTRAVENOUS
AP
May 29, 2024
EQ 50MG BASE/VIAL
injectable
Prescription
INTRAVENOUS
AP
May 29, 2024
Manufacturing Plant Locations
New
Biocon Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Biocon Pharma as present at those locations.
Country
City
Firm Name
India
Bengaluru
Biocon Pharma Limited
3. FRESENIUS KABI USA
Fresenius Kabi Usa Llc has filed for 2 different strengths of generic version for Micafungin Sodium. Given below are the
details of the strengths of this generic introduced by
Fresenius Kabi Usa.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 50MG BASE/VIAL
injectable
Prescription
INTRAVENOUS
AP
May 17, 2019
EQ 100MG BASE/VIAL
injectable
Prescription
INTRAVENOUS
AP
May 17, 2019
Manufacturing Plant Locations
New
Fresenius Kabi Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Usa as present at those locations.
Country
City
Firm Name
United States
Melrose Park
Fresenius Kabi USA, LLC
Wilson
Fresenius Kabi USA, LLC
Skokie
Fresenius Kabi USA LLC
Grand Island
Fresenius Kabi USA, LLC
North Andover
Fresenius Kabi USA, LLC
Bensenville
Fresenius Kabi USA LLC (FK USA)
Melrose Park
Fresenius Kabi USA LLC
Lake Zurich
Fresenius Kabi USA, LLC
4. HIKMA
Hikma Pharmaceuticals International Ltd has filed for 2 different strengths of generic version for Micafungin Sodium. Given below are the
details of the strengths of this generic introduced by
Hikma.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 50MG BASE/VIAL
injectable
Prescription
INTRAVENOUS
AP
Jul 9, 2021
EQ 100MG BASE/VIAL
injectable
Prescription
INTRAVENOUS
AP
Jul 9, 2021
Manufacturing Plant Locations
New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
Country
City
Firm Name
United States
Eatontown
Hikma Pharmaceuticals USA, Inc.
Cherry Hill
Hikma Pharmaceuticals USA Inc.
Dayton
Hikma Injectables USA Inc
Carlsbad
Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Portugal
Terrugem Snt
Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman
Hikma Pharmaceuticals LLC
5. JIANGSU HANSOH PHARM
Jiangsu Hansoh Pharmaceutical Group Co Ltd has filed for 2 different strengths of generic version for Micafungin Sodium. Given below are the
details of the strengths of this generic introduced by
Jiangsu Hansoh Pharm.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 50MG BASE/VIAL
injectable
Prescription
INTRAVENOUS
AP
Jul 9, 2021
EQ 100MG BASE/VIAL
injectable
Prescription
INTRAVENOUS
AP
Jul 9, 2021
Manufacturing Plant Locations
New
Jiangsu Hansoh Pharm's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Jiangsu Hansoh Pharm as present at those locations.
Country
City
Firm Name
China
Lianyungang
Jiangsu Hansoh Pharmaceutical Group Co., Ltd
Lianyungang
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
6. MEITHEAL
Meitheal Pharmaceuticals Inc has filed for 2 different strengths of generic version for Micafungin Sodium. Given below are the
details of the strengths of this generic introduced by
Meitheal.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 50MG BASE/VIAL
injectable
Prescription
INTRAVENOUS
AP
Sep 28, 2022
EQ 100MG BASE/VIAL
injectable
Prescription
INTRAVENOUS
AP
Sep 28, 2022
7. XELLIA PHARMS APS
Xellia Pharmaceuticals Aps has filed for 2 different strengths of generic version for Micafungin Sodium. Given below are the
details of the strengths of this generic introduced by
Xellia Pharms Aps.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 50MG BASE/VIAL
injectable
Prescription
INTRAVENOUS
AP
Jun 2, 2021
EQ 100MG BASE/VIAL
injectable
Prescription
INTRAVENOUS
AP
Jun 2, 2021
8. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Micafungin Sodium. Given below are the
details of the strengths of this generic introduced by
Zydus Pharms.
